Literature DB >> 2317117

Anticardiolipin antibody negative occlusive vascular retinopathy in systemic lupus erythematosus.

P H Dessein, R F Gledhill, R A Asherson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2317117      PMCID： PMC1003996          DOI： 10.1136/ard.49.2.133-b

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

1.  Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome.

Authors:  R A Asherson; P Merry; J F Acheson; E N Harris; G R Hughes
Journal:  Ann Rheum Dis       Date:  1989-05       Impact factor: 19.103

2.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

3.  Lupus retinopathy. Patterns, associations, and prognosis.

Authors:  F J Stafford-Brady; M B Urowitz; D D Gladman; M Easterbrook
Journal:  Arthritis Rheum       Date:  1988-09

4.  Budd Chiari syndrome, visceral arterial occlusions, recurrent fetal loss and the "lupus anticoagulant" in systemic lupus erythematosus.

Authors:  R A Asherson; R P Thompson; N MacLachlan; E Baguley; P Hicks; G R Hughes
Journal:  J Rheumatol       Date:  1989-02       Impact factor: 4.666
  4 in total
  1 in total

1.  Anticardiolipin antibodies in patients from Malaysia with systemic lupus erythematosus.

Authors:  H W Jones; R Ireland; G Senaldi; F Wang; M Khamashta; A J Bellingham; K Veerapan; G R Hughes; D Vergani
Journal:  Ann Rheum Dis       Date:  1991-03       Impact factor: 19.103
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.